Gosnolds Emerson House Emerson House

Gosnolds Emerson House Emerson House

Services:
Facility Operation (e.g., Private, Public)
• Private non-profit organization

Language Services

• Sign language services for the deaf and hard of hearing

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Education and Counseling Services

• Substance use disorder education
• Hepatitis education, counseling, or support
• Family counseling
• HIV or AIDS education, counseling, or support
• Smoking/vaping/tobacco cessation counseling
• Individual counseling
• Health education services other than HIV/AIDS or hepatitis
• Group counseling

Testing

• TB screening
• Drug and alcohol oral fluid testing
• Metabolic syndrome monitoring
• HIV testing
• Testing for Hepatitis B (HBV)
• Breathalyzer or blood alcohol testing
• Drug or alcohol urine screening
• Testing for Hepatitis C (HCV)
• STD testing

Assessment/Pre-treatment

• Interim services for clients
• Comprehensive substance use assessment
• Complete medical history/physical exam
• Screening for substance use
• Screening for mental disorders
• Comprehensive mental health assessment
• Professional interventionist/educational consultant
• Screening for tobacco use
• Outreach to persons in the community

Gender Accepted

• Male
• Female

Recovery Support Services

• Mentoring/peer support
• Self-help groups
• Housing services
• Assistance with obtaining social services
• Recovery coach
• Employment counseling or training

Facility Smoking Policy

• Smoking permitted in designated area

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• Other contracted prescribing entity
• In-network prescribing entity

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

License/Certification/Accreditation

• State Substance use treatment agency
• The Joint Commission
• State department of health
• Drug Enforcement Agency (DEA)
• SAMHSA certification for opioid treatment program (OTP)

Payment/Insurance/Funding Accepted

• Federal military insurance (e.g., TRICARE)
• Private health insurance
• IHS/Tribal/Urban (ITU) funds
• Medicare
• State-financed health insurance plan other than Medicaid
• Federal, or any government funding for substance use treatment programs
• Cash or self-payment
• Medicaid

Special Programs/Groups Offered

• Criminal justice (other than DUI/DWI)/Forensic clients
• Clients with HIV or AIDS
• Members of military families
• Clients with co-occurring mental and substance use disorders

Facility Vaping Policy

• Vaping permitted in designated area

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Short-term residential
• Residential/24-hour residential

Type of Opioid Treatment

• Maintenance service with medically supervised withdrawal after stabilization
• Prescribes buprenorphine
• Prescribes naltrexone
• Buprenorphine maintenance
• Relapse prevention with naltrexone
• Accepts clients using MAT but prescribed elsewhere

Treatment Approaches

• Contingency management/motivational incentives
• Matrix Model
• Motivational interviewing
• Telemedicine/telehealth therapy
• Anger management
• Cognitive behavioral therapy
• Trauma-related counseling
• Relapse prevention
• 12-step facilitation
• Brief intervention
• Substance use disorder counseling

Transitional Services

• Discharge Planning
• Outcome follow-up after discharge
• Aftercare/continuing care
• Naloxone and overdose education

Ancillary Services

• Transportation assistance
• Social skills development
• Suicide prevention services
• Acupuncture
• Case management service
• Mental health services

Age Groups Accepted

• Young Adults
• Adults

External Opioid Medications Source

• No formal relationship with prescribing entity
• Other contracted prescribing entity

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Pharmacotherapies

• Naltrexone (oral)
• Medication for mental disorders
• Naltrexone (extended-release, injectable)
• Clonidine
• Non-nicotine smoking/tobacco cessation
• Lofexidine
• Medications for Hepatitis C treatment
• Nicotine replacement
• Medications for HIV treatment
• Acamprosate (Campral®)
• Buprenorphine (extended-release, injectable)
• Buprenorphine without naloxone
• Disulfiram
• Buprenorphine with naloxone